Regenesis Biomedical Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 120

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $1.36M

  • Investors
  • 11

Regenesis Biomedical General Information

Description

Developer of noninvasive regenerative medical products designed to improve the quality of life. The company offers a non-drug pain management device used for the palliative treatment of post-operative pain and edema of soft tissue, enabling doctors to effectively treat post-operative pain and edema in patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5301 North Pima Road
  • Suite 150
  • Scottsdale, AZ 85250
  • United States
+1 (877)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • 5301 North Pima Road
  • Suite 150
  • Scottsdale, AZ 85250
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenesis Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - PPP 07-Apr-2020 $1.36M Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2012 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Jun-2011 Completed Generating Revenue
3. Later Stage VC (Series B) 01-May-2008 Completed Generating Revenue
2. Later Stage VC 01-May-2008 $3.81M $7.23M Completed Generating Revenue
1. Later Stage VC (Series A) 03-Jun-2002 $3.42M $3.42M Completed Generating Revenue
To view Regenesis Biomedical’s complete valuation and funding history, request access »

Regenesis Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A2
Series A1 2,100,660 $0.001000 8% $0.58 $0.58 1x $0.58 7.47%
Series A 2,166,063 $0.001000 8% $1.58 $1.58 1x $1.58 7.71%
To view Regenesis Biomedical’s complete cap table history, request access »

Regenesis Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of noninvasive regenerative medical products designed to improve the quality of life. The company offers a non
Therapeutic Devices
Scottsdale, AZ
120 As of 2026

Cleveland, OH
 

Deerfield, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Regenesis Biomedical Competitors (5)

One of Regenesis Biomedical’s 5 competitors is SPR Therapeutics, a Formerly VC-backed company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SPR Therapeutics Formerly VC-backed Cleveland, OH
Baxter International Corporation Deerfield, IL
Boston Scientific Corporation Marlborough, MA
Curonix Private Equity-Backed Pompano Beach, FL
Medtronic Corporation Minneapolis, MN
You’re viewing 5 of 5 competitors. Get the full list »

Regenesis Biomedical Patents

Regenesis Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230158323-A1 Wearable pulsed electromagnetic field sensing device Pending 01-Nov-2021
WO-2023077161-A1 Wearable pulsed electromagnetic field sensing device Inactive 01-Nov-2021
US-20240278031-A1 Method and apparatus for providing pulsed electromagnetic field therapy Pending 09-Jun-2021
WO-2022261172-A1 Method and apparatus for providing pulsed electromagnetic field therapy Inactive 09-Jun-2021
US-20220392608-A1 Patient authentication and remote monitoring for pulsed electromagnetic field systems Inactive 03-Jun-2021 A61N2/02
To view Regenesis Biomedical’s complete patent history, request access »

Regenesis Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Regenesis Biomedical Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Springboard Enterprises Accelerator/Incubator Minority
Fulcrum Equity Partners Growth/Expansion Minority
Angel (individual) Minority
TGap Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Regenesis Biomedical FAQs

  • When was Regenesis Biomedical founded?

    Regenesis Biomedical was founded in 1997.

  • Where is Regenesis Biomedical headquartered?

    Regenesis Biomedical is headquartered in Scottsdale, AZ.

  • What is the size of Regenesis Biomedical?

    Regenesis Biomedical has 120 total employees.

  • What industry is Regenesis Biomedical in?

    Regenesis Biomedical’s primary industry is Therapeutic Devices.

  • Is Regenesis Biomedical a private or public company?

    Regenesis Biomedical is a Private company.

  • What is Regenesis Biomedical’s current revenue?

    The current revenue for Regenesis Biomedical is .

  • How much funding has Regenesis Biomedical raised over time?

    Regenesis Biomedical has raised $15.7M.

  • Who are Regenesis Biomedical’s investors?

    Springboard Enterprises, Fulcrum Equity Partners, , TGap Ventures, and are 5 of 11 investors who have invested in Regenesis Biomedical.

  • Who are Regenesis Biomedical’s competitors?

    SPR Therapeutics, Baxter International, Boston Scientific, Curonix, and Medtronic are competitors of Regenesis Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process